Search results for: Policy Analysis
Filter search results
Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase
3 October 2019
…patient outcomes). Conduct a preliminary retrospective analysis and theoretical testing of an outcome-based payment scheme based on the principles outlined in Phase 1, using data from Greater Manchester and in…
Health Care without Frontiers?
1 December 2000
…of cross-border flows are based on data which are now somewhat old and of dubious quality, suggesting that an important prerequisite for policy development in this area is the development…
Andrew Briggs
9 December 2024
…Cost-Effectiveness Analysis (Wiley). With a career dedicated to advancing methodological research and practical applications, Andrew continues to influence academia and policy in health and beyond. Professor Biggs was awarded the…
How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices
11 June 2025
…in our analysis. This analysis is subject to certain limitations. Some sources may not reflect the most recent policy developments. In addition, it can be challenging to verify how QALYs…
Incorporating Multiple Criteria in HTA
19 April 2011
…The authors argue for greater use of multiple criteria decision analysis (MCDA) as an aid to decision-making that is based on health technology assessment. What a health care system should…
Join us for the 2011 Annual Lecture
19 July 2011
…approaches. Policies and public attitudes toward the use of cost-effectiveness analysis in the U.S. and Britain continue to be very different. This year’s annual lecture, entitled ‘Cost per QALY in…
OHE in the Spotlight: Summer 2011
22 September 2011
…lessons that the UK might learn from other countries. (With Nancy Devlin, Jon has recently published an analysis of the options for operationalising VBP.) At the HESG meeting, Jon chaired…
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
Join OHE at ISPOR to discuss multiple criteria decision analysis, value based pricing, risk sharing, post-approval data collection and other key topics in HTA and health care decision making. The…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
…(OHE) and its collaborators, medicines for rare disease may be effectively valued using an innovative approach — multi-criteria decision analysis (MCDA) — that can include all relevant stakeholders, including patients’…